{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T01:01:01Z","timestamp":1794186061360,"version":"4.8.0"},"reference-count":51,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,25]],"date-time":"2025-02-25T00:00:00Z","timestamp":1740441600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004337","name":"Roche","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004337","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","ajog.org","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Obstetrics and Gynecology"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.ajog.2025.02.029","type":"journal-article","created":{"date-parts":[[2025,2,20]],"date-time":"2025-02-20T00:20:02Z","timestamp":1740010802000},"page":"453-460","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":42,"title":["An updated understanding of the natural history of cervical human papillomavirus infection\u2014clinical implications"],"prefix":"10.1016","volume":"232","author":[{"given":"Kathrine D.","family":"Lycke","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Steben","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzanne M.","family":"Garland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yin Ling","family":"Woo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret E.","family":"Cruickshank","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca B.","family":"Perkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neerja","family":"Bhatla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc D.","family":"Ryser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patti E.","family":"Gravitt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4616-9827","authenticated-orcid":false,"given":"Anne","family":"Hammer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Brotherton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimon","family":"Chatzistamatiou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Feldman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Kaufmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna Barbara","family":"Moscicki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret","family":"Stanley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Wentzensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajog.2025.02.029_bib1","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F","article-title":"Human papillomavirus is a necessary cause of invasive cervical cancer worldwide","volume":"189","author":"Walboomers","year":"1999","journal-title":"J\u00a0Pathol"},{"key":"10.1016\/j.ajog.2025.02.029_bib2","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1097\/OLQ.0000000000000193","article-title":"The estimated lifetime probability of acquiring human papillomavirus in the United States","volume":"41","author":"Chesson","year":"2014","journal-title":"Sex Transm Dis"},{"key":"10.1016\/j.ajog.2025.02.029_bib3","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1086\/657321","article-title":"Cervical human papillomavirus prevalence in 5 continents: meta-analysis of 1 million women with normal cytological findings","volume":"202","author":"Bruni","year":"2010","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.ajog.2025.02.029_bib4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1750-9378-5-19","article-title":"HPV - immune response to infection and vaccination","volume":"5","author":"Stanley","year":"2010","journal-title":"Infect Agent Cancer"},{"key":"10.1016\/j.ajog.2025.02.029_bib5","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/S0140-6736(07)61416-0","article-title":"Human papillomavirus and cervical cancer","volume":"370","author":"Schiffman","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.ajog.2025.02.029_bib6","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1111\/aogs.14362","article-title":"Evidence of latent HPV infection in older Danish women with a previous history of cervical dysplasia","volume":"101","author":"Hammer","year":"2022","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.ajog.2025.02.029_bib7","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.pvr.2019.02.004","article-title":"Whole tissue cervical mapping of HPV infection: molecular evidence for focal latent HPV infection in humans","volume":"7","author":"Hammer","year":"2019","journal-title":"Papillomavirus Research"},{"key":"10.1016\/j.ajog.2025.02.029_bib8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/srep20847","article-title":"Evidence of disrupted high-risk human papillomavirus DNA in morphologically normal cervices of older women","volume":"6","author":"Leonard","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.ajog.2025.02.029_bib9","doi-asserted-by":"crossref","first-page":"6183","DOI":"10.1158\/0008-5472.CAN-12-2635","article-title":"Contributions of recent and past sexual partnerships on incident human papillomavirus detection: acquisition and reactivation in older women","volume":"72","author":"Rositch","year":"2012","journal-title":"Cancer Res"},{"key":"10.1016\/j.ajog.2025.02.029_bib10","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1002\/ijc.28509","article-title":"Viral load and short-term natural history of type-specific oncogenic human papillomavirus infections in a high-risk cohort of midadult women","volume":"134","author":"Winer","year":"2014","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ajog.2025.02.029_bib11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/infdis\/jiaa557","article-title":"Rates of new human papillomavirus detection and loss of detection in middle-aged women by recent and past sexual behavior","volume":"223","author":"Paul","year":"2021","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.ajog.2025.02.029_bib12","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1093\/cid\/ciab985","article-title":"Proportion of incident genital human papillomavirus detections not attributable to transmission and potentially attributable to latent infections: implications for cervical cancer screening","volume":"75","author":"Malag\u00f3n","year":"2022","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ajog.2025.02.029_bib13","doi-asserted-by":"crossref","first-page":"e180","DOI":"10.1016\/S2214-109X(19)30488-7","article-title":"Global burden of cancer attributable to infections in 2018: a worldwide incidence analysis","volume":"8","author":"de Martel","year":"2020","journal-title":"Lancet Glob Health"},{"key":"10.1016\/j.ajog.2025.02.029_bib14","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.cmi.2019.09.006","article-title":"Primary HPV-based cervical cancer screening in Europe: implementation status, challenges, and future plans","volume":"26","author":"Maver","year":"2020","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.ajog.2025.02.029_bib15","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1002\/ijc.32950","article-title":"A\u00a0study of the risks of CIN3+ detection after multiple rounds of HPV testing: results of the 15-year cervical cancer screening experience at Kaiser Permanente Northern California","volume":"147","author":"Hammer","year":"2020","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ajog.2025.02.029_bib16","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1158\/1055-9965.EPI-09-1235","article-title":"Incidence, duration, and reappearance of type-specific cervical human papillomavirus infections in young women","volume":"19","author":"Insinga","year":"2010","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.ajog.2025.02.029_bib17","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1093\/infdis\/jiw074","article-title":"Incident detection of high-risk human papillomavirus infections in a cohort of high-risk women aged 25-65 years","volume":"214","author":"Winer","year":"2016","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.ajog.2025.02.029_bib18","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.pvr.2018.01.001","article-title":"Redetection of human papillomavirus type 16 infections of the cervix in mid-adult life","volume":"5","author":"Ermel","year":"2018","journal-title":"Papillomavirus Res"},{"key":"10.1016\/j.ajog.2025.02.029_bib19","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1093\/infdis\/jiad043","article-title":"Human papillomavirus intermittence and risk factors associated with first detections and redetections in the Ludwig-McGill cohort study of adult women","volume":"228","author":"Malagon","year":"2023","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.ajog.2025.02.029_bib20","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1093\/infdis\/jit175","article-title":"Redetection of cervical human papillomavirus type 16 (HPV16) in women with a history of HPV16","volume":"208","author":"Moscicki","year":"2013","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.ajog.2025.02.029_bib21","doi-asserted-by":"crossref","first-page":"2201","DOI":"10.1002\/ijc.30283","article-title":"Re-detection vs. new acquisition of high-risk human papillomavirus in mid-adult women","volume":"139","author":"Fu","year":"2016","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ajog.2025.02.029_bib22","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1093\/jnci\/djq356","article-title":"Long-term absolute risk of cervical intraepithelial neoplasia grade 3 or worse following human papillomavirus infection: role of persistence","volume":"102","author":"Kj\u00e6r","year":"2010","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.ajog.2025.02.029_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2020.100293","article-title":"A\u00a0study of type-specific HPV natural history and\u00a0implications for contemporary cervical cancer\u00a0screening programs","volume":"22","author":"Demarco","year":"2020","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.ajog.2025.02.029_bib24","doi-asserted-by":"crossref","first-page":"20","DOI":"10.7326\/M17-1609","article-title":"Effect of several negative rounds of human papillomavirus and cytology Co-testing on safety against cervical cancer: an observational cohort study","volume":"168","author":"Castle","year":"2018","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ajog.2025.02.029_bib25","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1038\/bjc.2017.309","article-title":"HPV-positive women with normal cytology remain at increased risk of CIN3 after a negative repeat HPV test","volume":"117","author":"Polman","year":"2017","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ajog.2025.02.029_bib26","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1004115","article-title":"Risk of cervical precancer among HPV-negative women in The Netherlands and its association with previous HPV and cytology results: a follow-up analysis of a randomized screening study","volume":"19","author":"Inturrisi","year":"2022","journal-title":"PLoS Med"},{"key":"10.1016\/j.ajog.2025.02.029_bib27","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1111\/ajt.14181","article-title":"Reactivation of latent HPV infections after renal transplantation","volume":"17","author":"Hinten","year":"2017","journal-title":"Am J Transplant"},{"issue":"Suppl 5","key":"10.1016\/j.ajog.2025.02.029_bib28","doi-asserted-by":"crossref","first-page":"F168","DOI":"10.1016\/j.vaccine.2012.06.045","article-title":"Human papillomavirus, human immunodeficiency virus and immunosuppression","volume":"30","author":"Denny","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.ajog.2025.02.029_bib29","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1177\/0956462419852224","article-title":"Safety and efficacy of human papillomavirus vaccination for people living with HIV: a systematic review and meta-analysis","volume":"30","author":"Zhan","year":"2019","journal-title":"Int J STD AIDS"},{"key":"10.1016\/j.ajog.2025.02.029_bib30","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1186\/s12916-023-02965-w","article-title":"Risk factors for human papillomavirus infection, cervical intraepithelial neoplasia and cervical cancer: an umbrella review and follow-up Mendelian randomisation studies","volume":"21","author":"Bowden","year":"2023","journal-title":"BMC Med"},{"issue":"Supplement 1","key":"10.1016\/j.ajog.2025.02.029_bib31","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1097\/LGT.0b013e318287d329","article-title":"2012 updated consensus guidelines for the management of abnormal cervical cancer screening tests and cancer precursors","volume":"17","author":"Massad","year":"2013","journal-title":"J\u00a0Low Genit Tract Dis"},{"key":"10.1016\/j.ajog.2025.02.029_bib32","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1093\/annonc\/mdp471","article-title":"European guidelines for quality assurance in cervical cancer screening. Second edition--summary document","volume":"21","author":"Arbyn","year":"2010","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ajog.2025.02.029_bib33","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1309\/AJCPTGD94EVRSJCG","article-title":"American society for colposcopy and cervical Pathology, and American society for clinical Pathology screening guidelines for the prevention and early detection of cervical cancer","volume":"137","author":"Saslow","year":"2012","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.ajog.2025.02.029_bib34","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1097\/LGT.0000000000000525","article-title":"2019 ASCCP risk-based management consensus guidelines for abnormal cervical cancer screening tests and cancer precursors","volume":"24","author":"Perkins","year":"2020","journal-title":"J\u00a0Low Genit Tract Dis"},{"key":"10.1016\/j.ajog.2025.02.029_bib36","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.ygyno.2020.01.023","article-title":"The risk of cervical cancer after cervical intraepithelial neoplasia grade 3: a population-based cohort study with 80,442 women","volume":"157","author":"Loopik","year":"2020","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ajog.2025.02.029_bib37","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1002\/ijc.31202","article-title":"Long-term risk of cervical cancer following conization of cervical intraepithelial neoplasia grade 3\u2014a Danish nationwide cohort study","volume":"142","author":"Sand","year":"2018","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ajog.2025.02.029_bib38","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.annonc.2019.11.004","article-title":"Incidence and mortality from cervical cancer and other malignancies after treatment of cervical intraepithelial neoplasia: a systematic review and meta-analysis of the literature","volume":"31","author":"Kalliala","year":"2020","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ajog.2025.02.029_bib39","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S1470-2045(11)70286-8","article-title":"Overall efficacy of HPV-16\/18 AS04-adjuvanted vaccine against grade 3 or greater cervical intraepithelial neoplasia: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial","volume":"13","author":"Lehtinen","year":"2012","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ajog.2025.02.029_bib40","doi-asserted-by":"crossref","first-page":"2632","DOI":"10.1002\/ijc.25940","article-title":"Impact of an HPV6\/11\/16\/18 L1 virus-like particle vaccine on progression to cervical intraepithelial neoplasia in seropositive women with HPV16\/18 infection","volume":"129","author":"Haupt","year":"2011","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ajog.2025.02.029_bib41","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1002\/ijc.26362","article-title":"Efficacy of the human papillomavirus (HPV)-16\/18 AS04-adjuvanted vaccine in women aged 15-25 years with and without serological evidence of previous exposure to HPV-16\/18","volume":"131","author":"Szarewski","year":"2012","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ajog.2025.02.029_bib42","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1093\/infdis\/jiu139","article-title":"Risk of newly detected infections and cervical abnormalities in women seropositive for naturally acquired human papillomavirus type 16\/18 antibodies: analysis of the control arm of PATRICIA","volume":"210","author":"Castellsague","year":"2014","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.ajog.2025.02.029_bib43","doi-asserted-by":"crossref","first-page":"2213","DOI":"10.1016\/S0140-6736(14)60920-X","article-title":"Efficacy, safety, and immunogenicity of the human papillomavirus 16\/18 AS04-adjuvanted vaccine in women older than 25 years: 4-year interim follow-up of the phase 3, double-blind, randomised controlled VIVIANE study","volume":"384","author":"Skinner","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.ajog.2025.02.029_bib44","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1056\/NEJMoa1917338","article-title":"HPV vaccination and the risk of invasive cervical cancer","volume":"383","author":"Lei","year":"2020","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ajog.2025.02.029_bib45","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1093\/jnci\/djab080","article-title":"Real-world effectiveness of human papillomavirus vaccination against cervical cancer","volume":"113","author":"Kjaer","year":"2021","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.ajog.2025.02.029_bib46","doi-asserted-by":"crossref","first-page":"2084","DOI":"10.1016\/S0140-6736(21)02178-4","article-title":"The effects of the national HPV vaccination programme in England, UK, on cervical cancer and grade 3 cervical intraepithelial neoplasia incidence: a register-based observational study","volume":"398","author":"Falcaro","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.ajog.2025.02.029_bib47","article-title":"Effect of the HPV vaccination programme on incidence of cervical cancer and grade 3 cervical intraepithelial neoplasia by socioeconomic deprivation in England: population based observational study","volume":"385","author":"Falcaro","year":"2024","journal-title":"BMJ"},{"key":"10.1016\/j.ajog.2025.02.029_bib48","article-title":"Risk of progression of cervical intraepithelial neoplasia grade 2 in human papillomavirus\u2013vaccinated and unvaccinated women: a population-based cohort study","author":"Krog","year":"2023","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2025.02.029_bib49","doi-asserted-by":"crossref","first-page":"696","DOI":"10.4161\/hv.5.10.9515","article-title":"Evaluation of quadrivalent HPV 6\/11\/16\/18 vaccine efficacy against cervical and anogenital disease in subjects with serological evidence of prior vaccine type HPV infection","volume":"5","author":"Olsson","year":"2009","journal-title":"Hum Vaccin"},{"key":"10.1016\/j.ajog.2025.02.029_bib50","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1093\/jnci\/djad189","article-title":"Human papillomavirus vaccination and anal high-grade precancerous lesions and cancer\u2014a real-worldeffectiveness study","volume":"116","author":"Baandrup","year":"2024","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.ajog.2025.02.029_bib51","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1093\/jnci\/djaa209","article-title":"Real-world effectiveness of human papillomavirus vaccination against vulvovaginal high-grade precancerous lesions and cancers","volume":"113","author":"Dehlendorff","year":"2021","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.ajog.2025.02.029_bib52","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/s10552-013-0320-z","article-title":"Carcinogenic HPV prevalence and age-specific type distribution in 40,382 women with normal cervical cytology, ASCUS\/LSIL, HSIL, or cervical cancer: what is the potential for prevention?","volume":"25","author":"Kjaer","year":"2014","journal-title":"Cancer Causes Control"}],"container-title":["American Journal of Obstetrics and Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937825001103?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937825001103?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,8]],"date-time":"2025-05-08T22:03:40Z","timestamp":1746741820000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002937825001103"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":51,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["S0002937825001103"],"URL":"https:\/\/doi.org\/10.1016\/j.ajog.2025.02.029","relation":{},"ISSN":["0002-9378"],"issn-type":[{"value":"0002-9378","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"An updated understanding of the natural history of cervical human papillomavirus infection\u2014clinical implications","name":"articletitle","label":"Article Title"},{"value":"American Journal of Obstetrics and Gynecology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajog.2025.02.029","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}